LABORATORY CORP AMER HLDGS's ticker is and the CUSIP is 50540RAG7. A total of 7 filers reported holding LABORATORY CORP AMER HLDGS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,499,000 | -3.2% | 668,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,549,000 | +13.1% | 668,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,370,000 | +133.0% | 668,000 | +90.9% | 0.00% | +100.0% |
| Q4 2018 | $588,000 | +68.5% | 350,000 | +133.3% | 0.00% | 0.0% |
| Q3 2018 | $349,000 | -3.3% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $361,000 | +11.1% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $325,000 | +1.2% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $321,000 | +3.2% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $311,000 | +7.6% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $289,000 | +12.0% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $258,000 | -20.6% | 150,000 | -25.0% | 0.00% | 0.0% |
| Q2 2015 | $325,000 | -25.3% | 200,000 | -33.3% | 0.00% | -50.0% |
| Q4 2014 | $435,000 | +6.4% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $409,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 9,350,000 | $17,222,000 | 1.58% |
| ZAZOVE ASSOCIATES LLC | 15,963,000 | $29,372,000 | 1.36% |
| AEGON USA Investment Management, LLC | 1,036,000 | $1,908,000 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 672,000 | $1,239,000 | 0.11% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 2,553,000 | $4,712,000 | 0.07% |
| THRIVENT FINANCIAL FOR LUTHERANS | 2,165,000 | $3,992,000 | 0.02% |
| Calamos Advisors LLC | 1,030,000 | $1,899,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 11,450,000 | $21,050,000 | 0.01% |
| Invesco Ltd. | 7,713,000 | $14,206,000 | 0.01% |
| MACQUARIE GROUP LTD | 1,000,000 | $1,850,000 | 0.00% |